We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
CDER performed 45 Class I recalls of human drugs deemed to have “very serious potential to cause harm, injury or death” in the last fiscal year, according to Joe Famulare, acting deputy director of CDER’s Office of Compliance.